Effective March 7, 2022:
A valid pre-travel COVID-19 test must be a COVID-19 NAAT test listed below or a supervised antigen test.
COVID-19 Nucleic Acid Amplification Test (NAAT)” means a type of viral diagnostic test for SARS-CoV-2, the virus that causes COVID-19. NAATs for SARS-CoV-2 specifically identify the RNA (ribonucleic acid) sequences that comprise the genetic material (nucleic acids) of the SARS-CoV-2 virus. The COVID-19 NAATs accepted in Bermuda are:
“COVID-19 PCR test” (reverse transcription polymerase chain reaction),
“COVID-19 LAMP test” (loop-mediated isothermal amplification), and,
“COVID-19 TMA test” (transcription mediated amplification).
A valid pre-arrival test result must meet the following standards:
- The COVID-19 test type must be indicated on the test result: RT-PCR, Rapid PCR, RT-LAMP, Antigen,
- The test must be performed by an accredited laboratory, healthcare provider or pharmacy
- The test result must be negative
- The test result must be on the laboratory’s official documentation and state full name of laboratory and contact information for laboratory (address, telephone, email)
- The test result must state the traveller's full name and date of birth and contact information (address, email)
- The test result must state the date the sample was collected which must be within the time frame listed below:
- For PCR, LAMP or TMA test, the date of the test must be no more than 4 days before the arrival date if arriving by air, or 4 days before the date of departure from the last port if arriving by sea
- For supervised antigen tests, the date of the test must be no more than 2 days before the arrival date if arriving by air, or 2 days before the date of departure from the last port if arriving by sea.
For any queries, contact Bermuda's COVID hotline at +1 (441) 444-2498 or TAapprovals@gov.bm
For more information visit out: Traveller's Testing FAQ's page.